CTSH Stock Recent News

Market Growth Driven by Increasing Demand for Real-World Evidence in Drug Development, Rising Focus on Value-Based Healthcare, Growing Cancer Incidence Globally, and Advancements in Data Analytics and AI Technologies REDDING, Calif., May 27, 2025 /PRNewswire/ -- According to a new market research report titled 'RWE Oncology Solutions Market by Component (Datasets, Consulting Services), Application (Drug Development & Approvals, Market Access & Reimbursement/Coverage Decisions, Medical Device Development & Approvals, Post-market Surveillance), End User, and Geography - Global Forecast to 2035', the RWE oncology solutions market is projected to reach $3.51 billion by 2035, up from an estimated $893 million in 2025, growing at a CAGR of 14.7% during the forecast period. The growth of this market is mainly driven by increasing demand for real-world evidence in drug development, rising focus on value-based healthcare, growing cancer incidence and prevalence globally, regulatory support for

Investors with an interest in Computers - IT Services stocks have likely encountered both Cognizant (CTSH) and Epam (EPAM). But which of these two companies is the best option for those looking for undervalued stocks?

Collaboration augments Cognizant's proven modernization services with Pega Blueprint to help enterprises reimagine legacy transformation projects and build agentified, future-ready enterprise systems. TEANECK, N.J.

Open-Sources Neuro® AI Multi-Agent Accelerator TEANECK, N.J. , May 22, 2025 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) today announced that it has open-sourced its Neuro® AI Multi-Agent Accelerator for research and academic use.

New study highlights how 2025 will be a turning point as technology redefines experience, operations, and value across the mortgage lifecycle. Key Findings: 74% of non-bank lenders are betting on innovation to drive differentiation, while only 21% believe they are leading the pack—revealing a significant gap and opportunity to innovate.

Here, we have picked three AI stocks, MSFT, CTSH and LRCX, which are well poised to benefit from AI's growing usage and ability to solve complex problems.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Examine Cognizant's (CTSH) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

Brokers have more insights into stocks and the macroeconomic backdrop. One must follow broker rating upgrades to pick stocks like DIS, CTSH and EXE.

Investors looking for stocks in the Computers - IT Services sector might want to consider either Cognizant (CTSH) or ServiceNow (NOW). But which of these two stocks offers value investors a better bang for their buck right now?